On March 1st, 2021, Johnson & Johnson began shipping nearly 4 million doses of its newly authorized COVID-19 vaccine across the U.S. Due to its ability to travel well—and last longer and in warmer temperatures than the Moderna and Pfizer vaccines— New Jersey plans to distribute the Johnson & Johnson vaccine to underserved communities, including communities of color, and vulnerable populations like people experiencing homelessness, those living in senior housing, homebound seniors, low-income residents, and people with disabilities.